跳至主要内容
临床试验/PACTR202009483194545
PACTR202009483194545招募中2 期

Evaluation of phytopharmaceuticals to improve the prognosis of Covid-19 disease in Togo.

niversity of Lome0 个研究点目标入组 250 人开始时间: 2020年9月20日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Patients over 18 years of age.
  • - Infected with a Covid-19 infection confirmed by a specific PCR.
  • - Hospitalized.
  • - Fever or cough
  • - No signs of respiratory distress
  • - Naïve of specific treatment for Covid-19.
  • - Informed consent signed by the patient.

排除标准

  • - Renal insufficiency (eGFR <30 ml/min, CKD-EPI formula).
  • - AST or ALT > 3 times normal
  • - Cirrhosis (stage = Child-Pugh B).
  • - Pregnancy or breastfeeding.
  • - Dementia or any other condition that does not allow for informed consent.
  • - Any reason that, at the discretion of the investigator, would compromise patient safety and cooperation in the trial.

研究者

发起方
niversity of Lome

相似试验